CHGA and squamous cell carcinoma: Nevertheless, the results of our present study confirmed the fact that poorly differentiated/basaloid squamous cell carcinomas must be differentiated from esophageal small-cell carcinomas by means of neuroendocrine markers (synaptophysin/chromogranin A) and a squamous-basal marker (e.g., p40).